The European Medicines Agency initiates investigation into Novo Nordisk's diabetes treatment Ozempic and weight-loss drug Saxenda, following concerns of suicidal thoughts raised by Iceland's health authority In response to three reported instances of patients contemplating suicide or self-harm, the European Medicines Agency … [Read more...] about EU Investigated Weight-Loss Drugs Ozempic Due to Reports of Suicidal Ideation